Company profile
Tabomedex Biosciences, Inc. company profile
Tabomedex focuses on the R&D of new drugs related to type 2 diabetes. They mainly study the mechanism of action of MK2 and achieve the effect of controlling blood glucose level by inhibiting MK2, namely inhibiting the effect of downstream avtivating enzymes.
Business identity
- Website
- http://tabomedex.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2013-01-01, Year
Headquarters
- Headquarters
- Panora, Iowa, United States
- Country code
- US
- Continent
- North America